[Prospective analysis of conservative treatment of acute coronary syndrome]
Insights
Thrombolysis significantly improved coronary reperfusion and survival rates for acute myocardial infarction (MI) patients compared to heparin and aspirin alone. Conservative interventions show varying outcomes based on treatment and MI type.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Acute coronary syndrome (ACS) management involves various interventions.
- Conservative (non-invasive) strategies are employed for ACS patients.
- Understanding outcomes of conservative ACS treatment is crucial for clinical practice.
Purpose of the Study:
- To analyze in-hospital and intermediate outcomes in ACS patients receiving conservative interventions.
- To compare the effectiveness of thrombolysis versus heparin and aspirin in acute myocardial infarction (MI).
- To evaluate survival rates based on treatment strategies and MI subtypes.
Main Methods:
- Retrospective analysis of 341 patients with ACS.
- Inclusion of patients treated with conservative (non-invasive) interventions.
- Comparison of outcomes between thrombolysis and heparin/aspirin groups for MI.
- Assessment of survival at hospital discharge and 6 months post-intervention.
Main Results:
- Coronary reperfusion achieved in 59% of MI patients with thrombolysis vs. 27% with heparin/aspirin.
- In-hospital survival: 91% (thrombolysis) vs. 82% (no thrombolysis).
- 6-month survival: 86% (thrombolysis) vs. 70% (no thrombolysis), 79% (non-Q-wave MI), 88% (unstable angina).
Conclusions:
- Thrombolysis demonstrates superior efficacy in achieving coronary reperfusion and improving survival for acute myocardial infarction.
- Conservative management outcomes vary, highlighting the importance of reperfusion strategies.
- Further research into optimizing non-invasive ACS treatments is warranted.
Abstract:
The in-hospital and intermediate outcomes in 341 patients with acute coronary syndrome treated with conservative (non-invasive) interventions were analysed. The coronary reperfusion was achieved in 59% patients with acute myocardial infarction (MI) treated with thrombolysis, but in 27% patients with MI treated only heparin and aspirin. In-hospital survival was 91% in 93 patients with MI treated with thrombolysis and 82% in 71 patients with MI without thrombolysis. On 6 month survival was 86% in patients with MI treated with thrombolysis, 70% in patients with MI without thrombolysis, 79% in patients with non-Q-wave MI and 88% in patients with unstable angina.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome V: Nursing Management
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Angina IV: Management
